Antibiotic resistance of Helicobacter pylori in Israeli children

Noam Zevit1, Itzhak Levy, Haim Shmuely

  • 1Department of Nutrition and Liver Diseases, Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petach-Tikva, Israel. nzevit@gmail.com

Insights

Antibiotic resistance in Helicobacter pylori is high in Israeli children, especially after prior treatment. Culture-based therapy is recommended for previously treated patients to address clarithromycin and metronidazole resistance.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Antimicrobial Resistance

Background:

  • Helicobacter pylori infection is a significant global health concern, particularly in pediatric populations.
  • Antibiotic resistance in H. pylori complicates treatment regimens and necessitates ongoing surveillance.

Purpose of the Study:

  • To determine antibiotic susceptibility patterns of H. pylori in Israeli children.
  • To assess the impact of prior antibiotic exposure on H. pylori resistance.
  • To investigate the presence of multiple H. pylori strains with varying resistance profiles in individual patients.

Main Methods:

  • A prospective case-series study involving 174 children (aged 1-18 years) undergoing gastroscopy.
  • Antibiotic susceptibility testing (amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin) performed using E-test on gastric biopsies.
  • Data collection via questionnaires on clinical and demographic information, including previous antibiotic use.

Main Results:

  • High primary resistance rates observed: 25% to clarithromycin and 19% to metronidazole in treatment-naïve children.
  • Significantly higher resistance rates in previously treated children: 42% for clarithromycin and 52% for metronidazole.
  • No resistance detected against amoxicillin, tetracycline, or levofloxacin.
  • Clarithromycin resistance correlated with prior macrolide use (p=0.033).
  • Simultaneous colonization by distinct H. pylori strains occurred in 3.8% of patients.

Conclusions:

  • Elevated rates of H. pylori resistance to clarithromycin and metronidazole are prevalent in Israeli pediatric populations.
  • Previous H. pylori treatment is a significant risk factor for developing resistance.
  • Culture-based treatment strategies are advisable for previously treated children to guide effective therapy.
  • The clinical significance of simultaneous colonization by multiple H. pylori strains warrants further investigation.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...